Insider · CIK 0001338535

BRENNAN MURRAY

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001338535

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-12-30	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−6,813 sh	$4.14	−$28.2K	72,620
2017-12-29	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+17.3K sh	—	—	79,433
2017-11-20	TCRTAlaunos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$2.73	+$54.6K	74,814
2017-11-20	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−12.6K sh	$4.32	−$54.6K	62,175
2017-11-20	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2017-06-12	TCRTAlaunos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$4.85	+$72.8K	68,114
2017-06-12	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−13.3K sh	$5.47	−$72.8K	54,814
2017-06-12	TCRTAlaunos Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2016-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−10.6K sh	$5.35	−$56.5K	53,114
2016-12-30	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+17.2K sh	—	—	63,672
2016-11-25	TCRTAlaunos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$6.49	+$97.4K	59,951
2016-11-25	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−13.5K sh	$7.22	−$97.3K	46,468
2016-11-25	TCRTAlaunos Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2016-03-10	TCRTAlaunos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$5.01	+$75.2K	54,161
2016-03-10	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−9,210 sh	$8.16	−$75.2K	44,951
2016-03-10	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2015-12-31	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+26.7K sh	—	—	39,161
2015-06-04	TCRTAlaunos Therapeutics, Inc.S Sale	Director	SSale	−5,837 sh	$9.55	−$55.7K	12,500
2015-06-03	TCRTAlaunos Therapeutics, Inc.S Sale	Director	SSale	−34.2K sh	$9.72	−$332K	18,337
2014-12-31	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2013-12-31	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2012-12-31	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2011-12-30	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2011-05-09	TCRTAlaunos Therapeutics, Inc.S Sale	Director	SSale	−15K sh	$6.57	−$98.6K	52,500
2010-12-31	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2010-03-31	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+15K sh	—	—	67,500
2010-03-31	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2009-12-31	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+7,500 sh	—	—	52,500
2009-12-31	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2009-09-23	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+30K sh	—	—	45,000
2009-05-13	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2007-06-18	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
Jan 34
BRENNAN MURRAY0001209191-18-000980
SEC(opens sec.gov)
Nov 224
BRENNAN MURRAY0001209191-17-062374
SEC(opens sec.gov)
Jun 144
ZIOPHARM ONCOLOGY INC0001209191-17-039840
SEC(opens sec.gov)
Jan 44
ZIOPHARM ONCOLOGY INC0001209191-17-000942
SEC(opens sec.gov)
Nov 294
ZIOPHARM ONCOLOGY INC0001209191-16-152302
SEC(opens sec.gov)
Mar 144
ZIOPHARM ONCOLOGY INC0001209191-16-108144
SEC(opens sec.gov)
Jan 54
ZIOPHARM ONCOLOGY INC0001209191-16-088686
SEC(opens sec.gov)
Jun 54
ZIOPHARM ONCOLOGY INC0001209191-15-050755
SEC(opens sec.gov)
Jan 24
ZIOPHARM ONCOLOGY INC0001209191-15-000206
SEC(opens sec.gov)

Companies

Alaunos Therapeutics, Inc.DirectorTCRT

Address

MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE

NEW YORK, NY, 10021